Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
MainStay Epoch International Choice Inv ICELX
- NAV / 1-Day Return 39.13 / −0.05 %
- Total Assets 216.9 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.510%
- Distribution Fee Level High
- Share Class Type Front Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 1.12%
- Turnover 34%
USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 10:09 PM GMT+0
Morningstar’s Analysis ICELX
Will ICELX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 40.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
AstraZeneca PLC ADR | 5.25 | 11.9 Mil | Healthcare |
Lloyds Banking Group PLC | 4.39 | 10.0 Mil | Financial Services |
Coca-Cola Europacific Partners PLC | 4.24 | 9.6 Mil | Consumer Defensive |
Keyence Corp | 4.18 | 9.5 Mil | Technology |
Asahi Group Holdings Ltd | 3.96 | 9.0 Mil | Consumer Defensive |
Sony Group Corp | 3.93 | 8.9 Mil | Technology |
Linde PLC | 3.77 | 8.6 Mil | Basic Materials |
Compass Group PLC | 3.62 | 8.2 Mil | Consumer Cyclical |
Airbus SE | 3.48 | 7.9 Mil | Industrials |
NN Group NV | 3.48 | 7.9 Mil | Financial Services |